TCL Archive In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved April 4, 1980
TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive NCI To Broaden Support, Especially For Staff, Through Core Grants to Comprehensive Centers November 21, 1975